FI20010905A0 - Nytt veterinärmedicinskt preparat - Google Patents
Nytt veterinärmedicinskt preparatInfo
- Publication number
- FI20010905A0 FI20010905A0 FI20010905A FI20010905A FI20010905A0 FI 20010905 A0 FI20010905 A0 FI 20010905A0 FI 20010905 A FI20010905 A FI 20010905A FI 20010905 A FI20010905 A FI 20010905A FI 20010905 A0 FI20010905 A0 FI 20010905A0
- Authority
- FI
- Finland
- Prior art keywords
- hydrogen
- choh
- hydroxy
- combined
- veterinary medicine
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- -1 methoxy, nitro, amino Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 229940122815 Aromatase inhibitor Drugs 0.000 abstract 1
- 241000282465 Canis Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003886 aromatase inhibitor Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 abstract 1
- 230000012173 estrus Effects 0.000 abstract 1
- 229910052736 halogen Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000001786 isothiazolyl group Chemical group 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 239000000273 veterinary drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20010905A FI20010905A0 (sv) | 2001-05-02 | 2001-05-02 | Nytt veterinärmedicinskt preparat |
| DK02722304.9T DK1399158T3 (da) | 2001-05-02 | 2002-05-02 | Ikke-terapeutisk fremgangsmåde til undertrykkelse af østrus hos ikke-humane pattedyr |
| EP02722304A EP1399158B1 (en) | 2001-05-02 | 2002-05-02 | Non-therapeutic method of suppressing oestrus in mammalian non-human animal |
| PCT/FI2002/000373 WO2002087571A1 (en) | 2001-05-02 | 2002-05-02 | Aromatase inhibitors as novel veterinary drugs |
| ES02722304T ES2386774T3 (es) | 2001-05-02 | 2002-05-02 | Método no terapéutico de supresión del estro en animales mamíferos no humanos |
| PT02722304T PT1399158E (pt) | 2001-05-02 | 2002-05-02 | Método não terapêutico de suprimir o estro num animal mamífero não humano |
| AT02722304T ATE555784T1 (de) | 2001-05-02 | 2002-05-02 | Nicht-therapeutische methode zur unterdrückung von oestrus bei tieren |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20010905A FI20010905A0 (sv) | 2001-05-02 | 2001-05-02 | Nytt veterinärmedicinskt preparat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI20010905A0 true FI20010905A0 (sv) | 2001-05-02 |
Family
ID=8561097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20010905A FI20010905A0 (sv) | 2001-05-02 | 2001-05-02 | Nytt veterinärmedicinskt preparat |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1399158B1 (sv) |
| AT (1) | ATE555784T1 (sv) |
| DK (1) | DK1399158T3 (sv) |
| ES (1) | ES2386774T3 (sv) |
| FI (1) | FI20010905A0 (sv) |
| PT (1) | PT1399158E (sv) |
| WO (1) | WO2002087571A1 (sv) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5112845A (en) * | 1986-03-07 | 1992-05-12 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
| US5352795A (en) * | 1986-03-07 | 1994-10-04 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
| TW210334B (sv) * | 1990-12-12 | 1993-08-01 | Ciba Geigy Ag | |
| GB2273704B (en) * | 1992-12-16 | 1997-01-22 | Orion Yhtymae Oy | Triazolyl diaryl selective aromatase inhibiting compounds |
| US5972921A (en) * | 1997-12-12 | 1999-10-26 | Hormos Medical Oy Ltd. | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |
| ES2256243T3 (es) * | 2000-07-10 | 2006-07-16 | Hormos Medical Ltd. | Metodo para tratar la criptorquidia. |
-
2001
- 2001-05-02 FI FI20010905A patent/FI20010905A0/sv unknown
-
2002
- 2002-05-02 DK DK02722304.9T patent/DK1399158T3/da active
- 2002-05-02 WO PCT/FI2002/000373 patent/WO2002087571A1/en not_active Ceased
- 2002-05-02 PT PT02722304T patent/PT1399158E/pt unknown
- 2002-05-02 AT AT02722304T patent/ATE555784T1/de active
- 2002-05-02 ES ES02722304T patent/ES2386774T3/es not_active Expired - Lifetime
- 2002-05-02 EP EP02722304A patent/EP1399158B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002087571A1 (en) | 2002-11-07 |
| ATE555784T1 (de) | 2012-05-15 |
| EP1399158B1 (en) | 2012-05-02 |
| EP1399158A1 (en) | 2004-03-24 |
| ES2386774T3 (es) | 2012-08-30 |
| PT1399158E (pt) | 2012-07-20 |
| DK1399158T3 (da) | 2012-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2485131C2 (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой и содержащие их противогрибковые средства | |
| ES2266212T3 (es) | Derivados de pirazol. | |
| RU2006118326A (ru) | Производное циклического амина, содержащее гетероарильный цикл | |
| MXPA04010622A (es) | Derivados de triazol como antagonistas de receptor de taquicinina. | |
| TWI244920B (en) | Compositions for improving fertility | |
| JP2006508065A5 (sv) | ||
| JP4880671B2 (ja) | １Ｈ−ピラゾール４−カルボキシルアミドその製造方法および１１β−ヒドロキシステロイドデヒドロゲナーゼとしてのその使用 | |
| HUE028051T2 (hu) | Neprilizin inhibitorok | |
| EP2269610A3 (en) | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors | |
| TW200843744A (en) | Dual-acting antihypertensive agents | |
| PE20030976A1 (es) | Piridinoilpiperidinas como agonistas de 5-ht1f | |
| HU230882B1 (hu) | Renin inhibitort tartalmazó kombinációs készítmények | |
| WO2007130075A8 (en) | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors | |
| CA2684105A1 (en) | Pyridine derivatives | |
| KR20100034763A (ko) | 11ｂ-하이드록시스테로이드 탈수소효소의 억제제 | |
| CN114845994B (zh) | 包含喹啉结构的驱虫化合物 | |
| US9963433B2 (en) | Anticancer drugs including the chemical structures of an androgen receptor ligand and a histone deacetylase inhibitor | |
| EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
| CA2409741A1 (en) | Tnf-.alpha. production inhibitors | |
| NO20062004L (no) | Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav | |
| RU2009144538A (ru) | Новые циклические пептидные соединения | |
| KR20230074840A (ko) | sGC 자극제의 고체 형태 | |
| BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
| EA200870224A1 (ru) | Бензо[f]изоиндол-2-илфенильные производные уксусной кислоты в качестве агонистов рецепторов ep | |
| JP2007505105A5 (sv) |